Lee et al. reported that the SIRT2 inhibitor AK-1 increased the ubiquitination of HIF-1α under hypoxic conditions, leading to HIF-1α degradation via a proteasomal pathway in A549 human lung cancer cells, HeLa cells, and HEK293 cells [22]. This evidence concerns the gene HIF1A and lung carcinoma.